A novel extracellular vesicle paradigm for the treatment of COVID-19 induced acute respiratory distress syndrome (ARDS)

Efficacy of mesenchymal stem cells (MSCs) for treatment of acute respiratory distress syndrome (ARDS) suggests bioactive bone marrow MSC extracellular vesicles (BM-MSC EVs) may be effective. A patient with severe COVID-19 associated ARDS who was presumed to expire was treated with a BM-MSC EV prepar...

Full description

Bibliographic Details

Published in:	Respiratory Medicine Case Reports
Main Authors:	Erik Osborn, John T. Ransom, Anastasiya Shulman, Vikram Sengupta, Mohammed Choudhry, Ali Hafiz, Jacob Gooden, Amy L. Lightner
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Subjects:	Mesenchymal stem cell MSC Extracellular vesicle EV ARDS
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213007124001102